CAM
TNDM icon

Connacht Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Connacht Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,856
Closed -$406K – 167
2022
Q2 		$406K Buy
6,856
+1,396
+26% +$115K 0.17% 99
2022
Q1 		$635K Buy
5,460
+1,359
+33% +$159K 0.33% 72
2021
Q4 		$617K Buy
4,101
+1,441
+54% +$195K 0.6% 58
2021
Q3 		$318K Sell
2,660
-1,048
-28% -$115K 0.21% 78
2021
Q2 		$361K Buy
+3,708
New +$331K 0.16% 87

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Connacht Asset Management's TNDM Position: Q3 2022 in Review

Connacht Asset Management sold out of Tandem Diabetes Care (TNDM) in Q3 2022, closing a stake of 6,856 shares — an estimated $406K sold.

Connacht Asset Management first reported a position in TNDM in Q2 2021 and held it in 5 quarters. The position peaked at $635K in Q1 2022. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

  • Connacht Asset Management reported no remaining Tandem Diabetes Care position as of Q3 2022 after selling out during the quarter.
  • Connacht Asset Management sold 6,856 Tandem Diabetes Care shares in Q3 2022, an estimated $406K.
  • Connacht Asset Management first reported a position in Tandem Diabetes Care in Q2 2021 and held it in 5 quarters.
  • Connacht Asset Management's Tandem Diabetes Care position peaked at $635K in Q1 2022.
  • 299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on Connacht Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.